Comparable stake leader
BlackRock, Inc.
SEC ownership of Cencora, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001140859.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
28 May 2026
- Public ticker
- COR on NYSE
- Parsed ownership sources
- 13F, 13D/G, and 3/4/5
- Largest SEC-reported holder
- BlackRock, Inc.
- Latest 13D/G holder
- BlackRock, Inc.
- Latest parsed ownership date
- 28 May 2026
- Issuer CIK
- 0001140859
- Issuer location
- Conshohocken, PA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Cencora, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
28 May 2026
13F
13D/G
3/4/5
Lead comparable stake: 8.5%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 8.5%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
8.5%
VANGUARD CAPITAL MANAGEMENT LLC
7.3%
Walgreens Boots Alliance, Inc.
5%
James F. Cleary
0.08%
Elizabeth S. Campbell
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
8.5%
from 13D/G
|
$6,265,094,040
19,943,637 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.3%
|
$4,464,011,076
14,210,260 shares
|
$0 | 31 Mar 2026 |
| Walgreens Boots Alliance, Inc. |
3/4/5
13D/G
10%+ Owner
|
5%
from 13D/G
|
$3,073,490,700
12,570,000 shares
|
— | 06 Feb 2025 |
| James F. Cleary |
3/4/5
Chief Financial Officer
|
0.08%
|
$60,046,108
160,357 shares
mixed-class rows
|
— | 11 Mar 2026 |
| Elizabeth S. Campbell |
3/4/5
Executive Vice President
|
0.02%
|
$12,302,694
30,706 shares
mixed-class rows
|
-$1,737,223 | 11 Mar 2026 |
| Dermot Mark Durcan |
3/4/5
Director
|
0.01%
|
$7,393,241
27,767 shares
|
+$1,065,040 | 28 May 2026 |
| Silvana Battaglia |
3/4/5
Executive Vice President
|
0.01%
|
$9,247,564
23,566 shares
mixed-class rows
|
-$1,791,085 | 11 Mar 2026 |
| Lon R. Greenberg |
3/4/5
Director
|
0.01%
|
$6,731,805
18,408 shares
|
— | 05 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$40,480,646.
Buys
$1,065,040
Insiders: 1
Sells
$41,545,686
Insiders: 5
Net
-$40,480,646
Shares: -131,590
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 4,000
Shares: 135,590
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 4,000 | 0 | $1,065,040 | $0 | +$1,065,040 |
| 3-6 | 0 | 24,346 | $0 | $8,495,940 | -$8,495,940 |
| 6-9 | 0 | 48,526 | $0 | $14,690,215 | -$14,690,215 |
| 9-12 | 0 | 62,718 | $0 | $18,359,530 | -$18,359,530 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 26 reporting-owner rows connected to Cencora, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
26
Largest Forms 3/4/5 holder
Walgreens Boots Alliance, Inc.
Net 12M change
-$40,480,645
Latest report
28 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. | 10%+ Owner | $3,073,490,700 | Filing P/S | 06 Feb 2025 | ||
| Steven H. Collis | Executive Chairman, Director | $90,872,392 | -$21,847,411 | -19% | Mixed | 16 Sep 2025 |
| James F. Cleary | Chief Financial Officer | $60,046,108 | Mixed | 11 Mar 2026 | ||
| Robert P. Mauch | President & CEO, Director | $28,217,026 | -$14,786,386 | -34% | Mixed | 20 Feb 2026 |
| John G. Chou | Executive Vice President | $17,854,361 | Mixed | 20 Dec 2021 | ||
| Elizabeth S. Campbell | Executive Vice President | $12,302,694 | -$1,737,223 | -12% | Mixed | 11 Mar 2026 |
| Silvana Battaglia | Executive Vice President | $9,247,564 | -$1,791,085 | -16% | Mixed | 11 Mar 2026 |
| Dermot Mark Durcan | Director | $7,393,241 | +$1,065,040 | +17% | Filing P/S | 28 May 2026 |
| Richard W. Gochnauer | Director | $6,830,112 | Mixed | 11 Mar 2024 | ||
| Lon R. Greenberg | Director | $6,731,805 | Mixed | 05 Mar 2026 | ||
| Lazarus Krikorian | SVP & Chief Accounting Officer | $5,887,853 | -$1,383,580 | -19% | Filing P/S | 01 Apr 2026 |
| Kathleen W. Hyle | Director | $5,795,693 | Mixed | 11 Mar 2024 | ||
| Jane E. Henney MD | Director | $5,416,630 | Mixed | 05 Mar 2023 | ||
| Henry Wadsworth McGee III | Director | $4,493,707 | Mixed | 09 Mar 2023 | ||
| Dennis M. Nally | Director | $4,107,380 | Median | 01 May 2026 | ||
| Michael J. Long | Director | $3,889,177 | Mixed | 05 Mar 2023 | ||
| Gina Clark | Executive Vice President | $3,603,540 | Mixed | 31 May 2024 | ||
| Leslie E. Donato | EVP & Chief Strategy Officer | $2,208,691 | Mixed | 01 Jul 2024 | ||
| Pawan Verma | EVP, Chief Data & Info Officer | $1,863,954 | Mixed | 20 Nov 2025 | ||
| Lorence H. Kim | Director | $1,492,421 | Mixed | 05 Mar 2026 |
Recent insider transactions for Cencora, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Dermot Mark Durcan | COR | Common Stock | Purchase | 16.8% | $1,065,040 | $266.26 | 4,000 | 27,767 | 28 May 2026 | Direct |
| Lauren M. Tyler | COR | Common Stock | Award | 2.67% | 99 | 3,809 | 01 May 2026 | Direct | ||
| Ellen G. Cooper | COR | Common Stock | Award | 14.2% | 99 | 796 | 01 May 2026 | Direct | ||
| Dennis M. Nally | COR | Common Stock | Award | 0.9% | 116 | 13,075 | 01 May 2026 | Direct | ||
| Lazarus Krikorian | COR | Restricted Stock Units | Award | 3,936 | 3,936 | 01 Apr 2026 | Direct | |||
| Silvana Battaglia | COR | Common Stock | Tax liability | -13.5% | -3,673 | 23,566 | 11 Mar 2026 | Direct | ||
| Silvana Battaglia | COR | Common Stock | Options Exercise | 44.7% | 8,415 | 27,239 | 11 Mar 2026 | Direct | ||
| Silvana Battaglia | COR | Restricted Stock Units | Options Exercise | -100% | -8,415 | 0 | 11 Mar 2026 | Direct | ||
| Elizabeth S. Campbell | COR | Common Stock | Tax liability | -16% | -5,842 | 30,706 | 11 Mar 2026 | Direct | ||
| Elizabeth S. Campbell | COR | Common Stock | Options Exercise | 52.8% | 12,623 | 36,548 | 11 Mar 2026 | Direct | ||
| Elizabeth S. Campbell | COR | Restricted Stock Units | Options Exercise | -100% | -12,623 | 0 | 11 Mar 2026 | Direct | ||
| James F. Cleary | COR | Common Stock | Tax liability | -3.26% | -5,409 | 160,357 | 11 Mar 2026 | Direct | ||
| James F. Cleary | COR | Common Stock | Options Exercise | 8.24% | 12,623 | 165,766 | 11 Mar 2026 | Direct | ||
| James F. Cleary | COR | Restricted Stock Units | Options Exercise | -100% | -12,623 | 0 | 11 Mar 2026 | Direct | ||
| Ellen G. Cooper | COR | Common Stock | Award | 397.9% | 557 | 697 | 05 Mar 2026 | Direct | ||
| Dennis M. Nally | COR | Common Stock | Award | 4.49% | 557 | 12,959 | 05 Mar 2026 | Direct | ||
| Lauren M. Tyler | COR | Common Stock | Award | 17.7% | 557 | 3,710 | 05 Mar 2026 | Direct | ||
| Werner Baumann | COR | Common Stock | Award | 17.8% | 557 | 3,687 | 05 Mar 2026 | Direct | ||
| Frank Clyburn | COR | Common Stock | Award | 47.7% | 557 | 1,724 | 05 Mar 2026 | Direct | ||
| Dermot Mark Durcan | COR | Common Stock | Award | 3.96% | 905 | 23,767 | 05 Mar 2026 | Direct | ||
| Lon R. Greenberg | COR | Common Stock | Award | 3.12% | 557 | 18,408 | 05 Mar 2026 | Direct | ||
| Lorence H. Kim | COR | Common Stock | Award | 15.8% | 557 | 4,081 | 05 Mar 2026 | Direct | ||
| Redonda Miller | COR | Common Stock | Award | 17.4% | 557 | 3,751 | 05 Mar 2026 | Direct | ||
| Lori J. Ryerkerk | COR | Common Stock | Award | 108% | 557 | 1,073 | 05 Mar 2026 | Direct | ||
| Robert P. Mauch | COR | Common Stock | Sale | -5.44% | $1,350,332 | $358.94 | -3,762 | 65,393 | 20 Feb 2026 | Direct |
| Robert P. Mauch | COR | Common Stock | Options Exercise | 5.75% | 3,762 | 69,155 | 20 Feb 2026 | Direct | ||
| Robert P. Mauch | COR | Non-qualified Stock Option (Right to Buy) | Options Exercise | -100% | -3,762 | 0 | 20 Feb 2026 | Direct | ||
| Robert P. Mauch | COR | Common Stock | Sale | -2% | $479,160 | $359.46 | -1,333 | 65,393 | 18 Feb 2026 | Direct |
| Ellen G. Cooper | COR | Common Stock | Award | 2700% | 135 | 140 | 30 Jan 2026 | Direct | ||
| Dennis M. Nally | COR | Common Stock | Award | 0.8% | 98 | 12,402 | 30 Jan 2026 | Direct | ||
| Lauren M. Tyler | COR | Common Stock | Award | 2.74% | 84 | 3,153 | 30 Jan 2026 | Direct | ||
| Robert P. Mauch | COR | Common Stock | Sale | -7.1% | $1,807,704 | $354.73 | -5,096 | 66,726 | 20 Jan 2026 | Direct |
| Robert P. Mauch | COR | Common Stock | Options Exercise | 5.53% | 3,763 | 71,822 | 20 Jan 2026 | Direct | ||
| Robert P. Mauch | COR | Non-qualified Stock Option (Right to Buy) | Options Exercise | -50% | -3,763 | 3,762 | 20 Jan 2026 | Direct | ||
| Silvana Battaglia | COR | Common Stock | Award | 0.15% | 27.34 | 18,824 | 31 Dec 2025 | Direct | ||
| Elizabeth S. Campbell | COR | Common Stock | Award | 0.14% | 33.53 | 23,925 | 31 Dec 2025 | Direct | ||
| Silvana Battaglia | COR | Common Stock | Sale | -8.19% | $578,565 | $345.00 | -1,677 | 18,796 | 19 Dec 2025 | Direct |
| Elizabeth S. Campbell | COR | Common Stock | Sale | -12.3% | $1,146,377 | $342.10 | -3,351 | 23,891 | 19 Dec 2025 | Direct |
| Robert P. Mauch | COR | Common Stock | Sale | -6.97% | $1,750,221 | $343.45 | -5,096 | 68,059 | 18 Dec 2025 | Direct |
| Robert P. Mauch | COR | Common Stock | Options Exercise | 5.42% | 3,763 | 73,155 | 18 Dec 2025 | Direct | ||
| Robert P. Mauch | COR | Non-qualified Stock Option (Right to Buy) | Options Exercise | -33.3% | -3,763 | 7,525 | 18 Dec 2025 | Direct | ||
| Robert P. Mauch | COR | Common Stock | Gift | -4.32% | -3,000 | 66,392 | 17 Dec 2025 | Direct | ||
| Lazarus Krikorian | COR | Common Stock | Sale | -19% | $1,383,580 | $343.24 | -4,031 | 17,154 | 17 Dec 2025 | Direct |
| James F. Cleary | COR | Common Stock | Tax liability | -15% | -26,952 | 153,143 | 17 Dec 2025 | Direct | ||
| James F. Cleary | COR | Common Stock | Options Exercise | 33.5% | 45,154 | 180,095 | 17 Dec 2025 | Direct | ||
| James F. Cleary | COR | Non-qualified Stock Option (Right to Buy) | Options Exercise | -100% | -45,154 | 0 | 17 Dec 2025 | Direct | ||
| Dennis M. Nally | COR | Common Stock | Gift | -8.7% | -1,173 | 12,304 | 17 Dec 2025 | Direct | ||
| Robert P. Mauch | COR | Common Stock | Tax liability | -0.91% | -638 | 69,392 | 15 Dec 2025 | Direct | ||
| Robert P. Mauch | COR | Common Stock | Options Exercise | 0.92% | 638 | 70,030 | 15 Dec 2025 | Direct | ||
| Robert P. Mauch | COR | Restricted Stock Units | Options Exercise | -4% | -638 | 15,322 | 15 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.